Info

CTMM-TraIT celebrates its 2000st user

Lucy Pike uses TraIT for sharing PET images for the PETRA project, aiming to validate interim FDG-PET as a predictive biomarker of response to lymphoma therapy

2015 has seen more than a doubling of researchers that enroll to use one of the tools and services provided by CTMM-TraIT.

At the end of November, Nikie Hoetjes, research analyst for the PETRA consortium at the VUmc, requested access to NBIA for Lucy Pike, a clinical scientist of the PET center of the Guy’s and St. Thomas Hospital in London.

Lucy Pike and Nikie Hoetjes

Lucy Pike (right) and Nikie Hoetjes (left) during a PETRA consortium meeting in Guy’s and St. Thomas’ in London.

PETRA (standing for PET Re‐Analysis) is an Alpe d’HuZes/KWF sponsored retrospective study aiming to validate interim FDG‐PET as a predictive biomarker of response to first-line non-Hodgkin’s lymphoma therapy. For this purpose, PET images of individual patients from several high quality clinical trials are being gathered by the various PETRA consortium partners, including the HOVON (NL), Lysarc (FR), PETAL study group (DE), as well as Guy’s and St. Thomas’ NHS Foundation Trust, where Lucy Pike works.

Making use of the TraIT ImageHub, Lucy will be uploading PET images of selected clinical trials onto the central TraIT NBIA image archive, where consortium partners will be able to visualize PETRA images in a secure way, using the TraIT Keosys viewer.

General information and results of image analysis will be combined with clinical data from the various studies within the TraIT tranSMART data warehouse. This PETRA database will be a comprehensive and unique shared database of individual patient data of studies on interim FDG‐PET, enabling research aiming at identifying an optimal implementation of FDG-PET for the treatment of lymphoma patients in daily clinical practice.

PETRA consortium meeting London

The VUmc PETRA research team and Guy’s and St. Thomas’ consortium partners during a PETRA consortium meeting in Guy’s and St. Thomas’ in London. From left to right:
Simone Pieplenbosch (PETRA research analyst), Nikie Hoetjes (PETRA research analyst), Coreline Burggraaff (PETRA PhD student), Otto Hoekstra (co Principal Investigator PETRA study), Riekie de Vet (co Principal Investigator PETRA study), Josée Zijlstra (Principal Investigator PETRA study), Sally Barrington (nuclear medicine specialist) and George Mikhaeel (clinical oncologist).

PETRA and TraIT teams

From left to right:
Riekie de Vet (co Principal Investigator PETRA study), Ruud Ross (TraIT), Nikie Hoetjes (PETRA research analyst), Coreline Burggraaff (PETRA PhD student), Jeroen Beliën (TraIT), Johan van Soest (TraIT)

For more information on the PETRA study, please contact Coreline Burggraaff.

For more information on TraIT solutions, please contact the TraIT service Desk.